1. Cytokeratin 18-associated Histone 3 Modulation in Hepatocellular Carcinoma: A Mini Review
- Author
-
Yih-Shyong Lai, Chiung-Chi Cheng, Yi-Hsiang Liu, and Yen-Chang Clark Lai
- Subjects
0301 basic medicine ,Oncology ,Cancer Research ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Histone Deacetylase 1 ,Review Article ,medicine.disease_cause ,Biochemistry ,Keratin 18 ,Histones ,03 medical and health sciences ,Histone H3 ,Cytokeratin ,0302 clinical medicine ,Internal medicine ,Genetics ,medicine ,Humans ,Immunoprecipitation ,Molecular Biology ,Keratin-18 ,biology ,Liver Neoplasms ,Acetylation ,HDAC1 ,030104 developmental biology ,Histone ,030220 oncology & carcinogenesis ,biology.protein ,Cancer research ,Plectin ,Histone deacetylase ,Carcinogenesis - Abstract
Unstable cytokeratins are associated with tumor transformation in the development of human hepatocellular carcinoma. We previously demonstrated that the cytokeratin 18 was modulated and that a histone H3-specific modification occured, among members of the histone family, during the development of human hepatocellular carcinoma. Evidence suggested that the modification of histone H3 was highly correlated with the modulation of cytokeratin 18 and probably plays an important role in tumorigenesis of hepatocytes. Aberrant expression of histone deacetylase leading to imbalance between acetylation and deacetylation of histones may exhibit regulatory roles in tumor transformation. Recently we found that overexpression of histone deacetylase-1 and hypoacetylation of histone H3 were associated with hepatocellular carcinoma. The underlying roles of histone H3 modulation are discussed in this mini-review article.
- Published
- 2017
- Full Text
- View/download PDF